NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/17/2026
Back to search
Official data from USPTO
EXPANDING LIFE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
EXPANDING LIFE
ST13
US500000099180612Class
5, 10
Filing
99180612
Registration
8174088
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
03/17/2026
Classification
Registered
Trademark type
Word
Nice classes
5, 10
Filing date
05/12/2025
Registration date
03/17/2026
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/17/2026
Last transaction
03/17/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
Paris, FR
Examiner
MATZINGER, AMY L
Law office
N90
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Nanobiotix
Representatives
Arturo Perez Guerrero
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical productsmedicalveterinary preparations for the treatment of gastrointestinal conditionshormonal and chemical imbalancessleep disorderscancerscentral nervous system disorderscardiovascularimmunologicalgastrointestinalmetabolic and infectious diseases; Health productspharmaceutical productsmedicalveterinary preparations for the treatment of gastrointestinal conditionshormonal and chemical imbalancessleep disorderscancerscentral nervous system disorderscardiovascularimmunologicalgastrointestinalmetabolic and infectious diseases; Radiological contrast substances for medical use; Chemical reagents for medical use; Bacteriological preparations for medical use; Biological reagents for medical use; Chemical preparations for medical or pharmaceutical usefor the treatment of cancercentral nervous system disorderscardiovascularimmunologicalgastrointestinalmetabolic and infectious diseases ;Diagnostic preparations for medical purposes; Pharmaceutical products for medical usenamely for the diagnosis and treatment of tumors;
Class 10
Medical apparatus and instruments for use in surgery; Prosthetic tissues for parietalvisceralvascular usefor intracerebral administration; Artificial implant and prosthesestissues for parietalvisceralvascular usefor intracerebral administration; Radiotherapy apparatus; Apparatus for medical diagnosis for detecting cancer or neurological disorders
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/17/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/27/2026
PUBO
PUBLISHED FOR OPPOSITION
01/27/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/21/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/02/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/21/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/21/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/21/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/26/2025
GNRT
NON-FINAL ACTION E-MAILED
09/26/2025
CNRT
NON-FINAL ACTION WRITTEN
09/26/2025
DOCK
ASSIGNED TO EXAMINER
09/25/2025
MAFR
APPLICATION FILING RECEIPT MAILED
05/12/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/12/2025
NWAP
NEW APPLICATION ENTERED
05/12/2025
Continuous trademark protection
Get notified about every new filing that threatens EXPANDING LIFE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.